Submitted by Anonymous (not verified) on 26 August 2025 - 16:03
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 24, Status: Authorised